Type I Hypersensitivity Completed Phase 3 Trials for Tyrosine (DB00135)

Also known as: Immediate Hypersensitivity / Hypersensitivity, Immediate / Immediate Type Hypersensitivity / Immediate hypersensitivity reaction / Immediate hypersensitivity reactions / Allergen-mediated IgE Allergy / Immediate hypersensitivity (disorder) / Hypersensitivity type I / Hypersensitivity type I NOS / Immunoglobulin E-mediated allergic disorder (disorder)

DBCOND0030618 (Type I Hypersensitivity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00414141Efficacy and Safety/Tolerability of Grass MATA MPLTreatment